MORE►
clinical trials
Early-stage oncology companies will have the opportunity to compete for lab and office space at BioLabs Pegasus Park, a $25,000 cash prize, and invaluable guidance from industry professionals. [Photo: BioLabs at Pegasus Park]
Secretome Therapeutics Closes $20.4M Financing Round to Advance Heart Therapies
by Lance Murray | Dec 9, 2024
Baltimore-based Secretome—which has a presence at BioLabs at Pegasus Park in Dallas and offices in Plano—said the financing will enable it to initiate clinical trials for its lead asset, STM-01, and further advance its drug development pipeline.
by Lance Murray |
Jan 19, 2024
Marc Chamberlain, M.D., has been appointed as the Chief Medical Officer at Starlight Therapeutics.
Starlight Therapeutics is a Dallas-based Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options.
In his role as CMO, Chamberlain will oversee the company’s upcoming clinical trials focused on several serious and complex brain-related conditions: glioblastoma and other high-grade gliomas (aggressive types of brain tumor), brain metastases in adults (secondary brain tumors originating from cancer elsewhere in the body), and two types of pediatric brain tumors — atypical teratoid rhabdoid tumors (ATRT) and diffuse intrinsic pontine glioma (DIPG)....
MORE►
by Quincy Preston and Lance Murray |
Oct 20, 2023
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
MORE►
by Quincy Preston |
Oct 20, 2023
The Dallas-based customer experience hub of the Advanced Research Projects Agency for Health had its official launch yesterday at Pegasus Park. The hub's first mission: making it easier for Americans from across the country to take part in clinical trials, through the Advancing Clinical Trial Readiness Initiative.
MORE►
Lynne Faust balances a global pharamaceutical role and her love of equestrian sports. Photo illustration: Lynne Faust and Adobe Illustrator generative fill
Straddling Worlds: How Lynne Faust Balances a Thriving Life Science Career With Her Love for Equestrian Sports in Dallas-Fort Worth
by Nicole Ward, DRC Data Journalist | Jun 28, 2023
Organic chemist Lynne Faust is a master at helping companies accelerate drug development at STA Pharmaceuticals, a top-tier contract research and development manufacturer. A move to Weatherford, 25 miles west of Fort Worth, didn't just catalyze her career—it also spurred on her long-time passion for competitive horseback riding, making her life a unique mix of test tubes and trotting.
MORE►
by Lance Murray |
Jun 22, 2023
"There are over 10,000 rare diseases that affect millions of people worldwide, and most of them are genetic," notes UT Southwestern's Steven Gray (above, with Susan Iannaccone, M.D.). Testing on a total of eight genetic diseases has been approved for funding by the Bespoke Gene Therapy Consortium and other organizations.
MORE►
by Lance Murray |
Mar 22, 2023
Nanoscope Therapeutics has enlisted the expertise of Vicente Anido Jr., Ph.D. to help the company advance its goal of developing sight-restoring gene therapies for retinal degenerative diseases. Anido's appointment as a strategic adviser is expected to support Nanoscope's clinical and corporate strategies, especially as the company progresses towards the potential commercialization of MCO-010.
MORE►
by David Seeley |
Apr 20, 2022
Reveles' new DCT management platform broadens access to clinical trials by enabling patients to participate—without leaving their homes.
The technology includes enabling eConsent from existing and potential patients; online video and audio between patients and healthcare providers; direct data collection including real-time data, compliance, and status view featuring eSource, eDiaries, devices, wearables, questionnaires, and surveys; and telemedicine tools.
MORE►
[Image: iStock Photo, bestbrk. Illustration: India Edwards]
Dallas’ Peloton Therapeutics Exits to Merck in $2.2B Deal
by Lance Murray | May 22, 2019
The clinical-stage oncology company develops small molecule drugs to treat kidney cancer and other diseases. Its renal cell carcinoma drug is in a Phase II clinical trial.
MORE►
by Payton Potter |
May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
by Lance Murray |
Oct 12, 2018
Also, you'll learn how Galderma has boosted its R&D investment and boosted its clinical trials. Here are some of the research projects underway in North Texas that could make lives better.
MORE►
by Lance Murray |
Dec 1, 2017
Researchers are making discoveries and breakthroughs at laboratories and institutions all across North Texas. Here are some of their stories.
MORE►
